Trial · NCT07882147
Diagnostic Accuracy and Utility of ZTE Added to Routine MRI
NCT07882147, Not yet recruiting, Amal Ahmed Helmy
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Diagnostic Accuracy and Utility of ZTE Added to Routine MRI. Trials, record NCT07882147. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882147
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Diagnostic Accuracy and Utility of ZTE Added to Routine MRI
- NCT number
- NCT07882147
- Status
- Not yet recruiting
- Enrollment
- 100 participants, estimated
- Lead sponsor
- Amal Ahmed Helmy
- Conditions
- Breast Cancer, MRI Imaging
- Interventions
- MRI
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Diagnostic Accuracy, Marker Conspicuity, and Image Quality of ZTE Breast MRI | Baseline | Primary Aims: To evaluate the diagnostic accuracy of adding 3D ZTE MRI to routine breast MRI for detecting microcalcifications, against mammography and, when available, histopathology; to assess biopsy-marker conspicuity and blooming artifact; to compare ZTE image quality and artifacts with routine sequences; and to determine whether ZTE fits the standard |
| Secondary | Utility and Feasibility of ZTE Breast MRI | Baseline | Secondary aims: to assess reader confidence and inter-reader agreement (κ \> 0.80), the correlation between ZTE-based density assessment and mammographic BI-RADS density, additional scan time and patient tolerance. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07882147
GET https://conductscience.org/api/trials/v1/NCT07882147/registered